comparemela.com

Latest Breaking News On - Prnewswire lyra therapeutics inc - Page 3 : comparemela.com

Lyra Therapeutics Announces Closing of $100 5 Million Private Placement

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,.

Kathryn morrisMaria palasisHarlanw waksalHealth partnersExchange commissionPrnewswire lyra therapeutics incLyra therapeutics incNantahala capital managementVenrock healthcare capital partnersSamsara biocapitalPerceptive advisorsNorth bridge venture partnersPura vidaChief executive officerExecutive chairmanSecurities act

Lyra Therapeutics Announces $100 5 Million Private Placement

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA) today announced that it has entered into a securities purchase agreement to sell securities in a private.

United statesKathryn morrisPrnewswire lyra therapeutics incLyra therapeutics incSecurities actPrivate securities litigation reform actAnnual reportLyra therapeutics

Lyra Therapeutics to Report Third Quarter 2021 Financial Results on November 9

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,.

Kathryn morrisPrnewswire lyra therapeutics incLyra therapeutics incInvestor relationsLyra therapeuticsPrivate securities litigation reform actQuarterly reportHealth care amp hospitalsMedical pharmaceuticalsConference call announcements

vimarsana © 2020. All Rights Reserved.